Joint drug trial success boosts Amgen stock.

The entities involved

• Amgen →

  American multinational biopharmaceutical company

  • Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
  • Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
• AstraZeneca →

  British-Swedish pharmaceutical company

  • AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Mon 11:04
  • Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Sat 18:52

Related events

• Amgen acquired Horizon Therapeutics, a company whose portfolio included a drug discovered by AstraZeneca.Tue 21:48
• Amgen and AstraZeneca partnered on a Phase 3 CROSSING trial for the drug TEZSPIRE.Aug 27
• The market is reacting to the news of Novartis' drug trial failures, specifically impacting Amgen's stock performance on the Nasdaq exchange.Sep 12
• Novartis' drug failure has negatively impacted Amgen's financial outlook.Sep 8
• Amgen and Novartis have developed similar drugs aimed at treating heart conditions.Sep 7